// App-Quantinova.ai

TCT-261 : Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial

Researchers

Presenter

  • Julia Ellert

Principal Investigators

  • Evald Christiansen

  • Michael Maeng

  • Bent Raungaard

  • Christian Juhl Christian Juhl Terkelsen

  • Svend Eggert Jensen

  • Steen Dalby Kristensen

  • Johnny Kahlert

  • Hans Erik Botker

Medical Centers

  • Zealand University Hospital, Aarhus N, Denmark

  • OUH, Esbjerg, Denmark

  • Odense University Hospital, Odense, Denmark

  • Aarhus University Hospital, Aarhus, Denmark

  • Aarhus University Hospital, Aarhus, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Crofelemer

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim